BioLife Solutions Inc
$ 22.37
0.81%
21 Apr - close price
- Market Cap 1,071,777,000 USD
- Current Price $ 22.37
- High / Low $ 22.86 / 21.84
- Stock P/E N/A
- Book Value 7.72
- EPS -0.25
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.03 %
- 52 Week High 29.62
- 52 Week Low 17.86
About
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
Analyst Target Price
$32.40
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-12 | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-02-26 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-02-29 | 2023-11-09 | 2023-08-08 | 2023-05-10 |
| Reported EPS | 0.039 | 0.042 | -0.33 | 0.0355 | -0.016 | -0.0175 | -0.5 | -0.23 | -0.3 | -0.3 | -0.23 | -0.32 |
| Estimated EPS | -0.0038 | -0.0113 | -0.03 | -0.035 | -0.0567 | -0.09 | -0.14 | -0.28 | -0.34 | -0.37 | -0.2 | -0.21 |
| Surprise | 0.0428 | 0.0533 | -0.3 | 0.0705 | 0.0407 | 0.0725 | -0.36 | 0.05 | 0.04 | 0.07 | -0.03 | -0.11 |
| Surprise Percentage | 1126.3158% | 471.6814% | -1000% | 201.4286% | 71.7813% | 80.5556% | -257.1429% | 17.8571% | 11.7647% | 18.9189% | -15% | -52.381% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.01 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: BLFS
2026-04-17 15:09:01
Utah Medical Products (UTMD) has seen its shares rise 31.5% over the past year, outperforming the industry, due to its strong niche positioning, global diversification, and robust financial health. While the company benefits from favorable long-term healthcare trends and clinician-driven innovation, it faces challenges from regulatory burdens, competitive pressures, and a valuation higher than the industry average. Long-term investors might find UTMD's fundamentals appealing, but new investors might consider waiting for a more favorable entry point.
2026-04-10 21:09:07
BioLife Solutions EVP and Chief Scientific Officer Mathew Aby J. had 515 shares of common stock withheld by the company to cover tax obligations at $19.27 per share, due to the release of restricted stock units. This was not an open-market trade. After this transaction, he directly holds 390,167 shares of BioLife Solutions common stock.
2026-04-10 21:09:06
Todd Berard, Chief Marketing Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a routine insider transaction where 293 shares of common stock were withheld for tax obligations related to the release of restricted stock units. This was not an open-market sale, and after the transaction, Berard directly holds 163,768 shares. The filing indicates a neutral impact and sentiment on the company.
2026-04-10 21:09:06
BioLife Solutions Inc. CFO Troy Wichterman had 844 shares of common stock withheld on April 8, 2026, to cover tax obligations arising from the vesting of restricted stock units. The shares were valued at $19.27 each, and Wichterman now holds 216,056 shares directly. This transaction was a tax-withholding disposition, not an open-market sale, and is a common method for handling taxes on equity compensation.
2026-04-08 23:40:06
Wall Street analysts project a potential 70.78% upside for BioLife Solutions (BLFS), with an average price target of $32.67. While price targets alone might be misleading, the company also boasts a Zacks Rank #1 (Strong Buy) due to strong earnings estimate revisions, suggesting potential for near-term stock price movement. Investors are advised to use price targets as a starting point for further research, coupled with critical skepticism.
2026-04-08 23:09:06
This article provides detailed stock information for BioLife Solutions Inc. (NASDAQ: BLFS), including its current stock price, performance metrics, key statistics, technical and fundamental analysis ratings from ChartMill, and insights into its latest earnings report and analyst forecasts. The company specializes in biopreservation tools for cells and tissues.
